FormulaFolio Investments’s Antares Pharma, Inc. ATRS Stock Holding History

FormulaFolio Investments’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,645	Closed	-$94K	–	848
2020 Q4	$94K	Sell	23,645 -56,891	-71%	-$184K	﹤0.01%	647
2020 Q3	$217K	Hold	80,536	–	–	0.01%	295
2020 Q2	$221K	Buy	80,536 +59,290	+279%	+$165K	0.01%	266
2020 Q1	$50K	Buy	21,246 +2,125	+11%	+$7.23K	﹤0.01%	280
2019 Q4	$90K	Hold	19,121	–	–	﹤0.01%	357
2019 Q3	$64K	Buy	19,121 +1,260	+7%	+$4.15K	﹤0.01%	333
2019 Q2	$59K	Buy	+17,861	New	+$51.7K	﹤0.01%	313

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

FormulaFolio Investments's ATRS Position: Q1 2021 in Review

FormulaFolio Investments sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 23,645 shares — an estimated $94K sold.

FormulaFolio Investments first reported a position in ATRS in Q2 2019 and held it in 7 quarters. The position peaked at $221K in Q2 2020. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

FormulaFolio Investments reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
FormulaFolio Investments sold 23,645 Antares Pharma, Inc. shares in Q1 2021, an estimated $94K.
FormulaFolio Investments first reported a position in Antares Pharma, Inc. in Q2 2019 and held it in 7 quarters.
FormulaFolio Investments's Antares Pharma, Inc. position peaked at $221K in Q2 2020.
171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on FormulaFolio Investments's 13F filing for Q1 2021, filed 28 May 2021.